<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nephropathy induced by aristolochic acid (AA) containing herbs</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nephropathy induced by aristolochic acid (AA) containing herbs</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nephropathy induced by aristolochic acid (AA) containing herbs</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc E De Broe, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary C Curhan, MD, ScD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In 1991, clinicians in Belgium noted an increasing number of women who presented with acute, often near end-stage kidney disease (ESKD) following exposure to aristolochic acid (AA) at a weight reduction clinic [<a href="#rid1">1,2</a>]. An initial survey of seven nephrology centers in Brussels identified 14 women under the age of 50 years who had presented with advanced kidney failure due to biopsy-proven chronic tubulointerstitial nephritis over a three-year period; nine of these patients had been exposed to the same slimming regimen [<a href="#rid1">1</a>]. A total of more than 300 cases have been identified, a third of whom have already undergone kidney transplantation.</p><p>The epidemiology is unknown, as is the risk for development of severe kidney damage. However, the publication of case reports from several countries in Europe and Asia, particularly in China, indicate that the incidence of herbal medicine-induced nephrotoxicity is more common than previously thought [<a href="#rid3">3-7</a>].</p><p class="headingAnchor" id="H2"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>The major lesion, which is located principally in the cortex, is extensive interstitial fibrosis with atrophy and loss of the tubules. Cellular infiltration of the interstitium is scarce. Thickening of the walls of the interlobular and afferent arterioles results from endothelial cell swelling. The glomeruli are relatively spared, and immune deposits are not observed. These findings suggest that the primary lesions may be centered in the vessel walls, thereby leading to ischemia and interstitial fibrosis.</p><p>An extremely high incidence of cellular atypia and urothelial (transitional cell) carcinoma of the renal pelvis, ureter, and bladder has been associated with AA nephropathy [<a href="#rid8">8-10</a>].</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>AA nephropathy is caused by exposure to AA, a family of compounds found in the plant genus Aristolochiaceae, including the <em>Aristolochia</em> and <em>Asarum</em> species (also known as birthwort or Dutchman's pipe) [<a href="#rid11">11</a>]. AA also causes urothelial malignancy [<a href="#rid12">12</a>] and was classified a human (class I) carcinogen by the World Health Organization International Agency for Research on Cancer.</p><p>Support for AA as the major nephrotoxin is provided by findings in animal models (rabbit, rat, and mice) of disease [<a href="#rid13">13-17</a>]. In one study, for example, rabbits were given intraperitoneal injections of AA (0.1 mg AA/kg five days a week for 17 to 21 months) [<a href="#rid13">13</a>]. Histologic examination of the kidneys and genitourinary tract revealed kidney hypocellular interstitial fibrosis and atypical and malignant uroepithelial cells.</p><p>However, it is not clear if AA has been part of the herbal preparations used by all patients [<a href="#rid1">1</a>]. Furthermore, AA (0.15 mg/tablet) has been used as an immunomodulatory drug for 20 years in Germany by thousands of patients, sometimes in doses comparable with that found in AA-containing slimming regimens; despite this exposure, there is no report relating chronic tubulointerstitial nephritis to AA in Germany.</p><p>The necessity to stimulate the intrarenal renin-angiotensin system (salt deprivation) to obtain fibro-interstitial lesions is consistent with the combined exposure concept observed with several potential nephrotoxins [<a href="#rid18">18</a>]. Blockade of the renin-angiotensin system, however, does not prevent kidney interstitial fibrosis by AA [<a href="#rid19">19</a>]. How far transdifferentiation and apoptosis play an important role in this fast-developing type of chronic tubulointerstitial disease of the kidneys is still not clear [<a href="#rid20">20</a>]. One study suggests that AA induces tubular epithelial cell death via apoptosis by dephosphorylation of signal transducer and activator of transcription 3 (STAT3) and posttranslational activation of p53, supporting the hypothesis that p53 promotes kidney injury in AA nephropathy [<a href="#rid21">21</a>].</p><p>Another uncertain factor is why only some patients exposed to the same herbal preparations develop kidney disease. Females appear to be at greater risk than males. Other possibly important factors include toxin dose, batch-to-batch variability in toxin content, individual differences in toxin metabolism, and a genetically determined predisposition toward nephrotoxicity and/or carcinogenesis [<a href="#rid22">22</a>].</p><p>In one of the two studies showing a link between AA and carcinogenesis, an increased dose of AA was associated with an enhanced risk of carcinoma [<a href="#rid9">9</a>]. Tissue samples revealed AA-related deoxyribonucleic acid (DNA) adducts, indicating a possible mechanism underlying the development of malignancy. The presence of these adducts was noted in another report of two patients with urothelial malignancy and AA nephropathy [<a href="#rid23">23</a>].</p><p>The demonstration of AA-derived DNA adducts in kidney cortical and urothelial tumor tissue of patients with documented Balkan endemic nephropathy (BEN) associated with the dominance of the A:T<em>→</em>T:A transversions in the p53 tumor suppressor gene mutational spectrum helped identify AA as an etiological agent of the upper tract malignancy spectra in urothelial cancers among BEN patients [<a href="#rid24">24,25</a>]. In addition, molecular epidemiological evidence associated urothelial-cell carcinoma of the upper urinary tract to dietary exposure to AA through the contamination of flour prepared from locally grown wheat grain in the endemic cohort [<a href="#rid26">26</a>]. In this study, aristolactam-DNA adducts were present in 70 percent of the endemic cohort (n = 67) and in 94 percent of subjects with A:T<em>→</em>T:A mutations in <em>TP53</em>. In contrast, neither aristolactam-DNA adducts nor A:T<em>→</em>T:A mutations were detected in tumors of upper urinary tract carcinoma patients (n =10) residing in nonendemic regions (ie, regions not exposed to AA). The authors proposed a molecular epidemiological approach using deoxyadenosine-aristolactam adducts and <em>TP53 </em>mutational spectra as biomarkers of exposure to and carcinogenic effects of AA in the evaluation of the disease in countries where <em>Aristolochia </em>species have been used for medicinal purposes.</p><p>The etiology of herbal medicine-induced nephrotoxicity and BEN is exposure to AA, a toxic component of all <em>Aristolochia </em>species. The slower progression toward end-stage kidney disease (ESKD) of patients with BEN has to do with lower doses of AA ingested during the consumption of contaminated bread as compared with the high dose of AA found in the herbal mixtures used by patients in the "slimming" clinic. The higher prevalence of women in the herbal medicine-induced nephrotoxicity cohorts can be attributed to the fact that young women are more likely to attend such clinics. The exact mechanism, however, by which exposure to AA results in chronic kidney damage remains uncertain.</p><p>In a study in mice, chronic administration of AA resulted in progressive kidney damage. AA activated Smad signaling, mediating epithelial–mesenchymal transition and kidney fibrosis via both transforming growth factor-beta-dependent and c-Jun N-terminal kinase (JNK)/mitogen-activated protein kinase (MAPK)-dependent mechanisms. The blockade of JNK and specific knock-down of Smad3, but not Smad2, were able to attenuate AA-stimulated collagen matrix expression and epithelial–mesenchymal transition [<a href="#rid17">17</a>]. AA was shown to be involved in the early proximal tubular dysfunction, manifested by low-molecular-weight proteinuria, as is found in herbal medicine-induced nephrotoxicity [<a href="#rid27">27</a>]. In another report of cell line and mouse model data, several key enzymes in mitochondrial respiration were identified as direct binding targets of AA [<a href="#rid28">28</a>].</p><p>In acute AA nephropathy in mice, AA adducts formed with DNA were associated with tubular epithelial cell apoptosis via p53-mediated signaling. AA induced dephosphorylation of STAT3 with subsequent activation of p53 and tubular epithelial cell apoptosis.</p><p>In contrast, overexpression of STAT3, p53 inhibition, or p53 knock-down with small interfering ribonucleic acid (RNA) attenuated AA-induced tubular epithelial cell apoptosis. This supports the hypothesis that p53 promotes kidney injury in acute AA nephropathy. These results have to be interpreted with caution with regard to humans in view of the slowly progressive character of the disease in patients. On the other hand, experiments conducted on tissue from patients with BEN indicate that p53 is also activated [<a href="#rid29">29</a>].</p><p>Activation of the MAPK pathway, with involvement of p38 and extracellular signal-regulated kinase subpaths, may be involved in the progression of AA-associated urothelial carcinoma [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H4"><span class="h1">PRESENTATION AND PROGNOSIS</span><span class="headingEndMark"> — </span>Affected patients typically present with chronic kidney function impairment. The blood pressure is either normal or only mildly elevated, protein excretion is only moderately increased (less than 1.5 g/day), and the urine sediment reveals only a few red and white cells. The elevation in protein excretion consists of both albumin and low-molecular-weight proteins that are normally filtered and reabsorbed by proximal tubular cells [<a href="#rid31">31</a>]. Thus, tubular dysfunction contributes to the proteinuria.</p><p>The plasma creatinine concentration at presentation has ranged from 1.4 to 12.7 mg/dL (123 to 1122 micromol/L) [<a href="#rid2">2</a>]. Kidney function tends to decline more rapidly than in other forms of interstitial nephritis [<a href="#rid32">32</a>]. As an example, in one study, among patients with AA nephropathy, compared with a control group of patients of similar age range and baseline serum creatinine, the creatinine doubling time was shorter (13 versus 52 months, respectively), and the two-year kidney survival time was worse (17 versus 74 percent, respectively) [<a href="#rid33">33</a>]. However, most patients who present with an initial plasma creatinine concentration below 2 mg/dL (176 micromol/L) appear to have relatively stable kidney function [<a href="#rid33">33</a>]. Progressive kidney failure resulting in eventual dialysis or transplantation may ensue in patients with more severe disease, even if further exposure to AA is prevented. The risk for progressive disease increases with the duration of exposure.</p><p>A similar clinical and pathologic process has been reported in a group of patients from Taiwan who had ingested herbal drugs from various sources and for different purposes. Their kidney biopsy samples showed histologic findings indicative of AA nephropathy, with extensive hypocellular interstitial fibrosis and atrophy and loss of tubules in all cases; these findings suggest that many different herbal drugs may contain AA [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H5"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>There is no proven, effective therapy for this disorder, which typically presents with marked interstitial fibrosis, but not prominent inflammation. Patients with AA nephropathy should avoid further exposure to AA and receive the same general care directed at slowing chronic kidney disease (CKD) progression as patients with CKD from other causes (see  <a class="medical medical_review" href="/z/d/html/7172.html" rel="external">"Overview of the management of chronic kidney disease in adults"</a>). An uncontrolled study suggested that corticosteroids may slow the rate of loss of kidney function [<a href="#rid34">34</a>].</p><p>The high incidence of cellular atypia of the genitourinary tract suggests that, at a minimum, these patients should undergo regular surveillance for abnormal urinary cytology. Whether more aggressive management strategies, such as bilateral native nephroureterectomies (particularly in those undergoing kidney transplantation), are required is unclear. Findings from one report support the more aggressive option [<a href="#rid8">8</a>].</p><p>Kidney transplantation is an effective modality for those who progress to end-stage kidney disease (ESKD). One report noted no recurrence in five such patients [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H2261092927"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Prevention of AA nephropathy and AA-associated cancers requires effective regulatory agency oversight of herbal preparations, food, and dietary supplements that may contain AA [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H743682697"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110749.html" rel="external">"Society guideline links: Chronic kidney disease in adults"</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Aristolochic acid (AA) nephropathy is an interstitial nephritis related to AA that was first described in 1991. A high incidence of cellular atypia and urothelial (transitional cell) carcinoma of the renal pelvis, ureter, and bladder has been associated with this disease. (See <a class="local">'Introduction'</a> above and <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology </strong>– The major histologic lesion in the kidney is interstitial fibrosis with atrophy and loss of the tubules in the kidney cortex. Thickening of the walls of the interlobular and afferent arterioles may be observed. Cellular infiltration of the interstitium is scarce, and glomeruli are spared. Immune deposits are not present. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Risk factors for development of AA nephropathy include female sex, toxin (AA) dose, and a genetically determined predisposition toward nephrotoxicity and/or carcinogenesis. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Affected patients typically present with chronic kidney function impairment and normal or only mildly elevated blood pressure. Protein excretion is only moderately increased (less than 1.5 g/day), and the urine sediment reveals only a few red and white cells. The elevation in protein excretion consists of both albumin and low-molecular-weight proteins. (See <a class="local">'Presentation and prognosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong>– There is no specific therapy for AA nephropathy. Patients with AA nephropathy should avoid further exposure to AA and receive the same general care directed at slowing chronic kidney disease (CKD) progression as patients with CKD from other causes. Kidney transplantation is an effective modality for those who progress to end-stage kidney disease (ESKD). Given the high incidence of cellular atypia of the genitourinary tract, patients should undergo regular surveillance for abnormal urinary cytology. (See <a class="local">'Treatment'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341:387.</a></li><li><a class="nounderline abstract_t">Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994; 24:172.</a></li><li><a class="nounderline abstract_t">Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000; 35:313.</a></li><li><a class="nounderline abstract_t">Wu Y, Liu Z, Hu W, Li L. Mast cell infiltration associated with tubulointerstitial fibrosis in chronic Aristolochic Acid Nephropathy. Hum Exp Toxicol 2005; 24:41.</a></li><li><a class="nounderline abstract_t">Guh JY, Chen HC, Tsai JF, Chuang LY. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis 2007; 49:626.</a></li><li><a class="nounderline abstract_t">Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74:158.</a></li><li><a class="nounderline abstract_t">Jelaković B, Dika Ž, Arlt VM, et al. Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid. Semin Nephrol 2019; 39:284.</a></li><li><a class="nounderline abstract_t">Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999; 33:1011.</a></li><li><a class="nounderline abstract_t">Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342:1686.</a></li><li><a class="nounderline abstract_t">Isnard Bagnis C, Deray G, Baumelou A, et al. Herbs and the kidney. Am J Kidney Dis 2004; 44:1.</a></li><li><a class="nounderline abstract_t">Ivić M. [Etiology of endemic nephropathy]. Lijec Vjesn 1969; 91:1273.</a></li><li><a class="nounderline abstract_t">Anandagoda N, Lord GM. Preventing aristolochic acid nephropathy. Clin J Am Soc Nephrol 2015; 10:167.</a></li><li><a class="nounderline abstract_t">Cosyns JP, Dehoux JP, Guiot Y, et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001; 59:2164.</a></li><li><a class="nounderline abstract_t">Debelle FD, Nortier JL, De Prez EG, et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 2002; 13:431.</a></li><li><a class="nounderline abstract_t">Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol 2003; 23:500.</a></li><li><a class="nounderline abstract_t">Nortier JL, Vanherweghem JL. For patients taking herbal therapy--lessons from aristolochic acid nephropathy. Nephrol Dial Transplant 2007; 22:1512.</a></li><li><a class="nounderline abstract_t">Zhou L, Fu P, Huang XR, et al. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol 2010; 298:F1006.</a></li><li><a class="nounderline abstract_t">De Broe ME. On a nephrotoxic and carcinogenic slimming regimen. Am J Kidney Dis 1999; 33:1171.</a></li><li><a class="nounderline abstract_t">Debelle FD, Nortier JL, Husson CP, et al. The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int 2004; 66:1815.</a></li><li><a class="nounderline abstract_t">Pozdzik AA, Salmon IJ, Debelle FD, et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 2008; 73:595.</a></li><li><a class="nounderline abstract_t">Zhou L, Fu P, Huang XR, et al. Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol 2010; 21:31.</a></li><li><a class="nounderline abstract_t">Diamond JR, Pallone TL. Acute interstitial nephritis following use of tung shueh pills. Am J Kidney Dis 1994; 24:219.</a></li><li><a class="nounderline abstract_t">Lord GM, Cook T, Arlt VM, et al. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001; 358:1515.</a></li><li><a class="nounderline abstract_t">Grollman AP, Shibutani S, Moriya M, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 2007; 104:12129.</a></li><li><a class="nounderline abstract_t">Schmeiser HH, Janssen JW, Lyons J, et al. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res 1990; 50:5464.</a></li><li><a class="nounderline abstract_t">Jelaković B, Karanović S, Vuković-Lela I, et al. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 2012; 81:559.</a></li><li><a class="nounderline abstract_t">Lebeau C, Arlt VM, Schmeiser HH, et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int 2001; 60:1332.</a></li><li><a class="nounderline abstract_t">Zhang Q, Luo P, Chen J, et al. Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics. Int J Biol Sci 2022; 18:2003.</a></li><li><a class="nounderline abstract_t">De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney Int 2012; 81:513.</a></li><li><a class="nounderline abstract_t">Chen IH, Luo HL, Su YL, et al. Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway. Molecules 2019; 24.</a></li><li><a class="nounderline abstract_t">Kabanda A, Jadoul M, Lauwerys R, et al. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995; 48:1571.</a></li><li><a class="nounderline abstract_t">Gökmen MR, Cosyns JP, Arlt VM, et al. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med 2013; 158:469.</a></li><li><a class="nounderline abstract_t">Reginster F, Jadoul M, van Ypersele de Strihou C. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant 1997; 12:81.</a></li><li><a class="nounderline abstract_t">Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 1996; 27:209.</a></li><li><a class="nounderline abstract_t">Das S, Thakur S, Korenjak M, et al. Aristolochic acid-associated cancers: a public health risk in need of global action. Nat Rev Cancer 2022; 22:576.</a></li></ol></div><div id="topicVersionRevision">Topic 7206 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8094166" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8048421" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10676733" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15850277" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Mast cell infiltration associated with tubulointerstitial fibrosis in chronic Aristolochic Acid Nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17472844" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18418355" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Aristolochic acid nephropathy: a worldwide problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31054628" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10352187" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Urothelial lesions in Chinese-herb nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10841870" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15211432" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Herbs and the kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5200813" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : [Etiology of endemic nephropathy].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25587104" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Preventing aristolochic acid nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11380818" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11805172" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13680539" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Toxic nephropathy: environmental chemicals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17405785" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : For patients taking herbal therapy--lessons from aristolochic acid nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20089673" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Mechanism of chronic aristolochic acid nephropathy: role of Smad3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10352210" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : On a nephrotoxic and carcinogenic slimming regimen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15496152" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18094681" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19892935" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8048429" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Acute interstitial nephritis following use of tung shueh pills.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11705569" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Urothelial malignant disease and Chinese herbal nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17620607" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Aristolochic acid and the etiology of endemic (Balkan) nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2201437" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22071594" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11576347" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35342337" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22373701" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31619002" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8544416" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Low molecular weight proteinuria in Chinese herbs nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23552405" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9027778" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Chinese herbs nephropathy presentation, natural history and fate after transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8659495" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35854147" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Aristolochic acid-associated cancers: a public health risk in need of global action.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
